The PULSE project emerges as a significant endeavor at the forefront of biomedical research, seeking to propel bioprinting technology to new heights, both on Earth and in space. With substantial ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has successfully 3D bioprinted the ...
As a bold venture at the forefront of biomedical research, the PULSE project is poised to develop paradigm-changing bioprinting technology for applications in space and on Earth. Awarded nearly 4 ...
FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH ™ 3D bioprinting. Recently published in APL ...
The field of therapeutic cloning has long sought to provide a way to create replacement organs and tissues from a patient’s own cells, with the most recent boost coming from the US Advanced Research ...
What just happened? Another technology that's long been the thing of sci-fi has taken its first steps to becoming a reality: 3D bioprinting complex human organs. The concept of being able to 3D-print ...
Organ transplants can save lives, but they’re plagued by long waiting lists and high chances of rejection. In a major step towards creating new organs on demand, Stanford scientists have now received ...
Redwire’s space biotech capabilities are creating valuable opportunities for the biopharma industry as microgravity allows for outcomes that aren’t possible on Earth, including bioprinting materials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback